CD86 and schistosomiasis: Whether these cells represent the modified DC phenotype that we recently identified after chronic maternal schistosomiasis (5), particularly by bearing the CD86 signature of activation in both cDC1 and cDC2 populations via schistosomiasis and schistosome antigens (29), may warrant further mechanistic investigation in the switch that occurs following treatment.